Loading insider details...
Latest Form 4 (Mar 30, 2026): Exercise/Conversion of 28,302 IMDX shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Mar 30, 2026 | Insight Molecular Diagnostics Inc. (IMDX) | Exercise/Conversion | 28,302 | n/a |
| Nov 4, 2025 | Insight Molecular Diagnostics Inc. (IMDX) | Exercise/Conversion | 50,000 | n/a |
| Sep 30, 2025 | Insight Molecular Diagnostics Inc. (IMDX) | Grant/Award | 235,000 | n/a |
| Mar 28, 2025 | Oncocyte Corp (OCX) | Grant/Award | 113,207 | n/a |
| Feb 11, 2025 | Oncocyte Corp (OCX) | Purchase | 97,561 | $200.0K |
| Dec 9, 2024 | Oncocyte Corp (OCX) | Purchase | 20,000 | $45.8K |
| Oct 15, 2024 | Oncocyte Corp (OCX) | Grant/Award | 200,000 | n/a |
| Oct 4, 2024 | Oncocyte Corp (OCX) | Purchase | 33,670 | $100.0K |
| Jun 24, 2024 | Oncocyte Corp (OCX) | Grant/Award | 200,000 | n/a |